当前位置：
X-MOL 学术
›
Eur. Neuropsychopharm.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Intermittent theta burst transcranial magnetic stimulation for methamphetamine addiction: A randomized clinical trial
European Neuropsychopharmacology ( IF 5.6 ) Pub Date : 2020-02-01 , DOI: 10.1016/j.euroneuro.2019.12.114 Hang Su 1 , Tianzhen Chen 1 , Haifeng Jiang 1 , Na Zhong 1 , Jiang Du 1 , Ke Xiao 2 , Ding Xu 2 , Weidong Song 2 , Min Zhao 3
European Neuropsychopharmacology ( IF 5.6 ) Pub Date : 2020-02-01 , DOI: 10.1016/j.euroneuro.2019.12.114 Hang Su 1 , Tianzhen Chen 1 , Haifeng Jiang 1 , Na Zhong 1 , Jiang Du 1 , Ke Xiao 2 , Ding Xu 2 , Weidong Song 2 , Min Zhao 3
Affiliation
Methamphetamine is the most commonly used illicit drug in China. We previously demonstrated that 10 Hz rTMS over the DLPFC reduces craving in methamphetamine users. Here, we applied intermittent theta burst stimulation (iTBS), a new form of rTMS, in a large sample at four clinical centers. 126 participants (age 31.64 ± 6.33; 106 men) with severe methamphetamine use disorder according to DSM-5 were randomized to receive either iTBS or sham over the DLPFC for four weeks (20 daily sessions, 900 pulses per day). Cue-induced craving and cognitive function were assessed before and after rTMS intervention. Relapse was followed up by urine test after discharge from the rehabilitation center. iTBS significantly reduced craving and improved cognition and sleep quality. This study suggests that rTMS may be a useful and safe treatment option for methamphetamine use disorder, warranting future large scale trials.
更新日期：2020-02-01
京公网安备 11010802027423号